Medindia

X

Anti-HIV Gel Did Not Prove Itself During Human Trials

by Savitha C Muppala on  December 16, 2009 at 6:17 PM AIDS/HIV News   - G J E 4
 Anti-HIV Gel Did Not Prove Itself During Human Trials
An anti-HIV vaginal gel did not meet expectations during human trials.
Advertisement

The anti-HIV gel called PRO 2000 contains a polymer of naphthalene sulphonate designed to physically prevent HIV from binding to cells lining the vagina. Women were given condoms to use in conjunction with it.

Advertisement
A smaller trial conducted in February appeared to lower the risk of infection by 30 per cent, but in larger trials the gel failed to show promising results.

The researchers found that of 3156 women who used the active gel in Uganda, Zambia, Tanzania and South Africa, 4.1 per cent became infected, versus 4.0 per cent of the 3112 users of the placebo.

"It very clearly doesn't work," New Scientist quoted chief investigator Sheena McCormack, of the MRC as saying.

"It tells us that the level of biological potency is not enough," she added.

On possible reason for its failure might be that the gel didn't perfectly cover vaginal surfaces, providing chinks for the virus to get through, said McCormack.

Another reason could be, she said, is that the active substance in the gel simply wasn't potent enough at blocking HIV.

McCormack added increasing its concentration, however, would make the gel impractically viscous.

"It's time to give up on this type of chemical, but not on the idea," said McCormack.

Source: ANI
SAV
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All